Teladoc Health, Inc. — Form 8-K
Filed August 3, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Teladoc Health appointed Mark V. Anquillare to its board of directors effective August 3, 2026. Anquillare is the former president and COO of Verisk Analytics with 30+ years of financial and executive leadership experience; he will serve on the Audit & Compensation committees. No financial terms, equity grants, or compensation details disclosed in the filing.
Why this rating
Board appointment is routine governance; no material financial impact, M&A, or strategic shift disclosed. Director adds relevant experience but represents standard board evolution.
See more from August 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.